Suchergebnisse - "Freier, Anna"

PubPharm (12)

1

The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis

enthalten in: Scientific reports | 2024

von Freier, A. | Lawson McLean, A. | Loeschner, D. | +2

2

The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity

enthalten in: Orphanet journal of rare diseases | 2023

von Lawson McLean, A. | Freier, A. | Lawson McLean, A. | +2

3

The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity

enthalten in: Orphanet journal of rare diseases | 2023

von Lawson McLean, A. | Freier, A. | Lawson McLean, A. | +2

4

The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity

enthalten in: Orphanet journal of rare diseases | 2023

von Lawson McLean, A. | Freier, A. | Lawson McLean, A. | +2

5

Supplementary data for the mediation effect of personality functioning – Gender differences, separate analyses of depression and anxiety symptoms and inferential statistics of the relationship between personality functioning and different types of child maltreatment

Erschienen: Marburg, Philipps-Universität Marburg, 2023

von Freier, A. | Kruse, J. | Schmalbach, B. | +5

6

Supplementary data for the mediation effect of personality functioning - Gender differences, separate analyses of depression and anxiety symptoms and inferential statistics of the relationship between personality functioning and different types of child maltreatment

enthalten in: Data in brief | 2022

von Freier, A. | Kruse, J. | Schmalbach, B. | +5

7

The mediation effect of personality functioning between different types of child maltreatment and the development of depression/anxiety symptoms - A German representative study

enthalten in: Journal of affective disorders | 2022

von Freier, A. | Kruse, J. | Schmalbach, B. | +5

8

Treatment with Sibutramine prior to Roux-en-Y Gastric Bypass leads to an Improvement of Metabolic Parameters and to a Reduction of Liver Size and Operative Time

enthalten in: Obesity surgery | 2009

von Aberle, J. | Freier, A. | Busch, P. | +4

9

Treatment with Sibutramine prior to Roux-en-Y Gastric Bypass leads to an Improvement of Metabolic Parameters and to a Reduction of Liver Size and Operative Time

enthalten in: Obesity surgery | 2009

von Aberle, J. | Freier, A. | Busch, P. | +4

10

Treatment with Sibutramine prior to Roux-en-Y Gastric Bypass leads to an Improvement of Metabolic Parameters and to a Reduction of Liver Size and Operative Time

enthalten in: Obesity surgery | 2009

von Aberle, J. | Freier, A. | Busch, P. | +4